سعر جينكو 40 مجم/مل محلول للفم 30 مل 2024

Ginko 40mg/ml oral soln. 30 ml — Ginkgo biloba (Mepaco).

• Well-established use (EU HMPC): ginkgo leaf dry extract medicines to improve age-related cognitive impairment and quality of life in adults with mild dementia.Population: Adults with mild dementia (EU HMPC)European Medicines Agency (EMA) HMPC
• Traditional use (EU HMPC): powdered ginkgo leaf for relief of heaviness of the legs and sensation of cold hands and feet associated with minor circulatory disturbances (after serious conditions excluded).Population: Adults (EU HMPC traditional use)European Medicines Agency (EMA) HMPC

• Most common adverse reaction with ginkgo leaf dry extract for mild dementia: headache (>1/10). For traditional circulation use: gastrointestinal disorders, headache and allergic reactions reported.General active-ingredient information · European Medicines Agency (EMA) HMPC

• Bleeding events (ocular, nasal, cerebral, gastrointestinal) have been reported with ginkgo leaf dry extract; use only after medical advice in patients with bleeding tendency or on anticoagulants/antiplatelets.General active-ingredient information · European Medicines Agency (EMA) HMPC

• Anticoagulants / antiplatelet agentsModerateGinkgo may increase bleeding risk when combined with anticoagulants or antiplatelet drugs; medical advice advised before use (EU HMPC risk summary).European Medicines Agency (EMA) HMPC

• Ginkgo biloba: Proposed neuroprotective, antioxidant and PAF-inhibitory effects; exact mechanism in dementia not fully established (EMA HMPC).